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Abstract
Background: Many soldiers are expected to carry heavy loads over extended distances, often resulting in physical
and mental fatigue. In this study, the design and testing of an autonomous leg exoskeleton is presented. The aim
of the device is to reduce the energetic cost of loaded walking. In addition, we present the Augmentation Factor, a
general framework of exoskeletal performance that unifies our results with the varying abilities of previously
developed exoskeletons.
Methods: We developed an autonomous battery powered exoskeleton that is capable of providing substantial
levels of positive mechanical power to the ankle during the push-off region of stance phase. We measured
the metabolic energy consumption of seven subjects walking on a level treadmill at 1.5 m/s, while wearing a
23 kg vest.
Results: During the push-off portion of the stance phase, the exoskeleton applied positive mechanical power with
an average across the gait cycle equal to 23± 2 W (11.5 W per ankle). Use of the autonomous leg exoskeleton
significantly reduced the metabolic cost of walking by 36± 12 W, which was an improvement of 8 ±3% (p= 0.025)
relative to the control condition of not wearing the exoskeleton.
Conclusions: In the design of leg exoskeletons, the results of this study highlight the importance of minimizing
exoskeletal power dissipation and added limb mass, while providing substantial positive power during the walking
gait cycle.
Background
The ability to carry substantial loads is required by many
professions, including many that may experience cogni-
tive deficits associated with the extreme physical de-
mands. For example, soldiers are often expected to carry
loads between 20–35 kg at speeds of 1.5-1.75 m/s for
over 10 km in a single march [1,2]. Wheeled vehicles,
however, are excellent at reducing the effort of carrying
substantial loads, but terrain and space restrictions often
limit the practicality of a vehicle and require the versatil-
ity of legged locomotion. Exoskeletons have the potential
to reduce the energetic cost of carrying such loads while
maintaining the flexibility of legged locomotion. To this
end, one of the first leg exoskeletons that posited to aug-
ment human legged locomotion was patented in the late
19
th century [3]. Since that time, interest in developing
exoskeletons to augment strength and endurance has in-
creased substantially, driven by the accelerating pace of
innovation in several mechanical and computer-related
disciplines [4-6]. Reducing the metabolic energy (i.e. en-
ergy from food) consumed by the human body during
legged locomotion is the goal of many exoskeletal tech-
nologies [7,8]. To our knowledge, no autonomous leg
exoskeleton system has been demonstrated to reduce
the metabolic demand for either walking, loaded walking
or running. In this work, “autonomous” describes a de-
vice that is self-contained and has all necessary com-
ponents on-board (e.g. power supply, controller, and
actuators, with no tether to external systems).
Researchers have attempted to reduce the metabolic
burden of load carriage by developing both passive and
active exoskeletons. Walsh et al. presented a device that
used springs in parallel with the ankle and hip joints along
with a variable damper at the knee [9]. A preliminary
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payload to the ground, but a 10% metabolic increase was
observed while wearing the exoskeleton. Kazerooni and
Steger developed a powerful lower extremity exoskel-
eton for load carriage with actuated hip, knee and
ankle joints [4]. The device allowed a user to walk at
1.3 m/s while carrying a 34 kg payload along with the
36 kg exoskeleton, but a metabolic improvement was
not shown. Both of these devices distributed the pay-
load weight through the structure of the exoskeletons,
thus reducing the weight borne by the human user.
The device presented by Walsh et al. achieved this by
outputting high knee damping during the early stance
phase of walking, while Kazerooni and Steger’sd e v i c e
provided active power at the joints to support the load.
However, the added mass of these sophisticated exo-
skeletons may have limited their abilities to improve
metabolism.
Exoskeletons have also been developed to assist with
unloaded locomotion. To achieve this goal a class of
passive exoskeletons have been designed. Donelan et al.
developed a device that uses an electromagnetic gener-
ator to harvest energy from the knee in a biomimetic
fashion [10,11]. Harvesting energy during periods of
negative power at the knee was less metabolically detri-
mental than continuous harvesting, but a metabolic in-
crease of over 20% was still observed. Recently, van Dijk
et al. presented an exoskeleton that has a spring span-
ning the ankle, knee and hip joints [12]. The average en-
ergy expenditure of walking increased by over 30% while
wearing the device. Although passive exoskeletons have
not reduced the metabolic cost of walking in healthy in-
dividuals, they have been shown to augment the ener-
getics of hopping [13,14]. Adding passive elements in
parallel with human joints are able to assist the muscles
during periods of spring like behavior. Such work is en-
couraging, but the extension to exoskeletons designed
for walking is unclear.
Many factors have hindered the development of an au-
tonomous performance-enhancing exoskeleton including
substantial added mass, limited mechanical power and
tethered energy supplies. Autonomous devices capable
of providing biologically equivalent levels of joint mech-
anical power necessary for locomotion have been investi-
gated, but these devices were cumbersome and heavy
[7,15,16]. Adding mass to the lower limbs requires add-
itional metabolic power, and the effects are amplified as
the mass is moved distally or further away from the hip
[17]. In an effort to reduce the weight of the worn exo-
skeleton, researchers have developed passive and quasi-
passive exoskeletons. Without an active actuator, these
devices are not able to provide levels of positive power
that overcome the negative metabolic effects of added
device mass [9,10,12].
Researchers have reduced weight and provided sub-
stantial positive power by tethering exoskeletons to an
energy supply not worn by the user [18-22]. The device
of Malcolm et al. was able to provide a 6% metabolic im-
provement during walking using pneumatic artificial
muscles. This device required a tether to an air supply
and extensive valving control network, thus distancing it
from an autonomous solution. Despite the tethered na-
ture of this devices, the study shows that it is possible to
reduce the metabolic cost of walking by assisting the
ankle with a lightweight device capable of providing
positive mechanical power.
The purpose of this study is to present the design and
testing of an autonomous leg exoskeleton capable of re-
ducing the metabolic cost of walking with load. The in-
tent of this research is to develop a technology that can
assist individuals who must carry loads for extended pe-
riods of time, such as soldiers. Our hypothesis is that a
leg exoskeleton capable of providing substantial levels of
positive mechanical power with minimal added distal
mass can provide such a metabolic benefit. In the evalu-
ation of this hypothesis, we augment the ankle joint be-
cause it is responsible for over 50% of the average
positive mechanical power during loaded walking [23].
We test the metabolic effect of the ankle exoskeleton
during walking with load carriage, and present the Aug-
mentation Factor, a general framework of exoskeletal
performance that unifies our results with the varying
abilities of previously developed exoskeletons.
Methods
Device design
The bilateral exoskeleton was designed to provide assist-
ance to the ankles during walking and was comprised of
three main assemblies: a pair of fiberglass struts attached
to each boot, unidirectional actuators mounted on the
anterior shank segments, and a battery and control pac-
kage worn on the waist (Figure 1). Each boot had a med-
ial and lateral fiberglass strut pinned to the front of the
boot, one at the medial and one at the lateral aspect of
the metatarsophalangeal joints. Each strut was coupled
to the heel of the boot via a lightweight inextensible
cord. The fiberglass struts were an extension of the
ankle-foot complex; when an anterior force was applied
to the proximal end of the strut it was converted into a
torque about the human ankle joint. The struts acted as
a moment arm (≈300 mm from the center of rotation of
the ankle joint) for the winch actuator to apply the
plantar-flexion assistive torque about the ankle joint.
There are four forces that acted on the strut: the force
of the winch cord on the proximal end of the strut, the
reaction force of the heel cord, the reaction force of the
pin attaching the distal end of the strut to the boot, and
the force of the ground on the distal end of the strut.
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was chosen in such a way that the reaction force at the
distal end of the strut was mostly in the vertical direc-
tion, which is provided by the ground and not the pin it-
self. This reduces the necessary size and weight of the
pin. The exoskeleton used a custom winch actuator
powered by a brushless DC (BLDC) motor. The 200 W
BLDC motor (model: 305015, Maxon Motor, Sachseln,
CH) actuated an 8 mm diameter spool through a belt
transmission with a 13:8 speed reduction. The spool
wrapped a 1 mm diameter ultra-high molecular weight
polyethylene cord (Dyneema, Stanley, NC) attached to
the proximal end of the fiberglass struts. The effective
transmission ratio between the BLDC motor and ankle
joint was approximately 120:1. The geometric transmis-
sion, comprised a spool, idler roller and strut, eliminated
the need for a traditional mechanical transmission, redu-
cing weight and complexity of the device.
The actuation systems of the exoskeleton were pow-
ered and controlled by the batteries and motor control-
lers worn around the waist. Sensory information was
provided to the controller; each boot contained instru-
mented insoles that detected heel and toe contact with
the ground (model: FSW, B&L Engineering, Santa Ana,
CA). The angular position of the BLDC motors were
measured with 500 count quadrature incremental optical
encoders (model: HEDL 5540, Maxon Motor, Sachseln,
CH). Each winch actuator had a corresponding BLDC
motor controller (model: SBL1360, Roboteq, Scottsdale,
AZ). The motor control loop iterated at 1000 Hz. The
motors, sensors and controllers were all powered by
two 24 V lithium-polymer batteries, with a capacity
Figure 1 Autonomous leg exoskeleton. (A) The autonomous exoskeleton applies torque about the human ankle joint during walking, adding
positive mechanical power to the wearer during the push-off portion of stance phase. During the swing phase, the device applies negligible
forces on the wearer by allowing small amounts of slack into the cord. The mechanism consists of a winch actuator and fiberglass struts that
directly apply a resultant torque about the ankle. (B) The winch actuator provides a torque on the ankle by winding the cord around the spool.
As the cord is tightened, a force is applied to the struts on either side of the leg. The winch actuator’s brushless motor applies the torque to the
ankle joint through a transmission that consists of the belt transmission stage in series with the geometric transmission stage comprising spool,
idler roller and strut.
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4.0 kg, with 1.7 kg worn on the waist and 2.3 kg worn on
the legs; a list of major component masses and locations
are shown in Table 1.
A biomechanically-inspired control strategy was im-
plemented to assist the user during the push-off portion
of stance phase and become transparent to the user dur-
ing swing phase. During stance phase, the controller
used a linear model of the motor to produce open loop
torque profiles. The details of the linear motor model
are further discussed in the Actuator Testing Protocol
subsection. Upon heel contact, the actuator behaved like
a soft virtual spring. The equilibrium position of the soft
virtual spring was set to the peak plantar-flexion angle
achieved just after heel strike. During the controlled
dorsiflexion region of stance phase, the winch actuator
applied a slight plantar-flexion torque that linearly in-
creased with the extension of the winch cord. This soft
virtual spring maintained tension in the cord and al-
lowed for a gradual increase in applied torque. The step
period of each subject was measured while not wea-
ring the exoskeleton. The controller was then set to ini-
tiate push-off assistance at 43% of the subject’s personal
gait cycle time [22]. During the push-off portion of
stance phase, the actuator exerted a large plantar-flexion
torque. Over 50 ms, the exoskeleton increased the ap-
plied plantar-flexion torque by approximately 120 Nm.
Subsequently, the applied plantar-flexion torque linearly
decreased with plantar-flexion angle. Once the actuator
reached 0.2 radians of ankle plantar flexion, the control-
ler entered a zero applied torque mode (swing phase).
This mode did not impede additional plantar flexion by
the biological ankle due to the nature of the unidirec-
tional actuator. During swing phase the exoskeleton pro-
vided slack in the drive cord to allow the user to freely
dorsiflex the biological ankle. To prevent such inter-
ference, the motor proceeded to the maximum angle
reached during controlled dorsiflexion of the previous
cycle. Stance phase was reinitiated when the controller
detected heel contact from the insole and any slack in
the cord was eliminated with a low applied torque that
was imperceptible to the user.
Actuator testing protocol
In order to reduce distal mass and complexity, the exo-
skeleton does not have an integrated force sensor; there-
fore, a linear model of the BLDC motor was used to
predict the mean mechanical power provided by the






τ ¼ ktI −J _ ω ð1bÞ
where I is the motor current, V is the applied voltage, kv
is the motor voltage constant, R is the terminal resist-
ance, ω and _ ω are the motor’s velocity and acceleration,
τ is the estimated motor torque, kt is the torque con-
stant, and J is the rotor inertia. The motor’s angle, as
measured by the encoder, was numerically differentiated
to get the motor velocity and then differentiated again
to get the motor acceleration. The velocity differenti-
ation was calculated by a single finite difference. The ac-
celeration was not calculated for real-time control due
to the low rotor inertia. However, the acceleration was
calculated by the central-difference method during post-
processing to estimate the mean power supplied by the
exoskeleton.
The mechanical power applied by the exoskeleton, p,
was calculated as the product of the estimated motor
power and experimentally determined mechanical power
efficiencies for regions of positive and negative power, η
+
and η
−. The mechanical power provided by the motor
was calculated as the product of τ and ω.T h ep o s i -
tive mechanical motor power was then scaled by η
+,
and the negative mechanical motor power was scaled
by η
−, to estimate the mechanical power applied by
the exoskeleton,
p ¼ ηþτω τω > 0
η−τω τω < 0
 
ð2Þ
The transfer efficiencies are defined as the ratio of the
mean measured mechanical power output of the actu-











exp are the experimentally measured
average positive and negative mechanical powers, and p
+
and p
− are the estimated average positive and negative
Table 1 Exoskeleton component mass distribution
Part Mass (g) Location
Footswitch 103 (x2) Foot
Strut assembly 273 (x2) Foot & Shank
Winch actuator 749 (x2) Shank
BLDC Controller 316 (x2) Waist
Batteries 400 (x2) Waist
Waist pack 281 Waist
Total 3963
Components that have both a right and left version are denoted with (x2),
and the shown mass is only for one exoskeletal leg.
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transfer efficiency of the actuator was experimentally
determined with an inline force sensor and acquisition
equipment (model: LRF350, Futek Advanced Sensor
Technology, Inc., Irvine, CA). The force sensor had a
max rated force of 890 N, and a sampling rate of 250 Hz
with 12 bit resolution. The winch actuator was used to
pull the inline force sensor and stiff elastic band at-
tached to the ground. The winch cord linear velocity
was derived from the motor rotational velocity, trans-
mission and spool diameter. The measured power, the
product of the cord linear velocity and measured force,
was compared to the estimated power, the product of
the motor velocity and estimated torque.
Walking protocol
The metabolic effect of the exoskeleton was tested on
seven male subjects (84±6 kg; 181± 5 cm; 23 ±4 years
old; mean± standard deviation) walking on a treadmill
at 1.5 m/s with a 23 kg weighted vest. These conditions
were chosen because they are consistent with typical
loads and speeds experienced by soldiers [1,2]. All sub-
jects were healthy and exhibited no gait abnormalities.
Only subjects with a foot size between 11 and 12.5 were
considered to ensure proper boot fit. This study was ap-
proved by the MIT Committee on the Use of Humans
as Experimental Subjects. Consent was obtained from
experimental participants after the nature and possible
consequences of the exoskeletal studies were explained.
The experimental protocol involved three walking trials
and one standing trial, all performed while wearing a
portable pulmonary gas exchange measurement instru-
ment (model: K4b
2, COSMED, Rome, IT). To account
for natural variation in metabolism, the control condi-
tion of no exoskeleton was tested before and after the
exoskeleton condition. The subjects first walked for
10 minutes with no device. After the subjects donned
the exoskeleton, they walked with the active device until
they reported being comfortable with the assistance, typ-
ically less than 5 minutes. The subjects then walked for
20 minutes with the exoskeleton (Additional file 1), in
order to allow for human-machine adaptation [24]. The
subjects then walked for another 10 minutes with no de-
vice. Finally, after the last no device trial, subjects stood
for 5 minutes with the weighted vest and no exoskeleton
in order to obtain the resting metabolic rate.
Metabolic rate was calculated from oxygen and carbon
dioxide exchange rates measured by the portable pul-
monary gas exchange measurement unit. The average
flow rates of the last two minutes of each trial were con-
verted into metabolic power using the equation deve-
loped by Brockway et al. [25]. The metabolic rate of
standing was subtracted from the metabolic rate of walk-
ing trials in order to obtain the net metabolic cost of
walking. The net metabolic rates measured from the two
control trials were averaged and compared to the net
metabolic rate of the exoskeleton trial [20,24]. A paired
t-test was used to test for metabolic improvement, with
the level of significance set at 0.05.
The mechanical and electrical powers of the exoskel-
eton were wirelessly recoded via Bluetooth at a sampling
rate of 100 Hz. The mechanical power applied by the
winch actuators were estimated through the linear
motor model and experimentally measured transfer effi-
ciency discussed in the previous section. The electrical
power was also recorded on a subset of four subjects by
measuring the battery voltage and current during a
period of walking with the exoskeleton.
Augmentation factor
A simple model to estimate the metabolic demand of an
exoskeleton design would be a valuable tool for de-
signers, but there are many factors which may affect
exoskeletal performance. Sawicki and Ferris presented
the performance index as a metric of measuring the rela-
tionship between applied positive exoskeleton mechan-
ical power and change in metabolic power [19]. A higher
performance index suggests that the exoskeleton is able
to more efficiently transfer mechanical power into meta-
bolic power. The efficient transformation of mechanical
power into metabolic power is important for autono-
mous systems that must carry their own energy supply.
The generality of the performance index enables the com-
parison of various exoskeletal designs, but it is limited to
developed and experimentally tested devices. The per-
formance index cannot make a prediction about the meta-
bolic performance of an untested exoskeleton.
As a resolution to this difficulty, we developed a gen-
eral model called the Augmentation Factor (AF) to pre-
dict the metabolic impact caused by a worn exoskeleton
at moderate walking speeds. Commonly, devices attempt
to improve metabolic rate by either providing positive
mechanical power to joints during phases of positive
muscle-tendon power, providing negative mechanical
power to joints during phases of negative muscle-tendon









estimates the change in metabolic power caused by a
worn exoskeleton. The AF predicts the metabolic im-
provement of a device in Watts. When computing the
AF for a device, a positive AF suggests that use of
an exoskeleton will result in a metabolic improvement
whereas a negative AF indicates that an exoskeleton
would increase walking metabolism. The AF balances
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metabolic improvement with those properties that cause
a metabolic detriment; the AF balances the mean posi-
tive mechanical power (p
+) supplied by an exoskeleton
with the net mechanical power dissipation (p
dis) and
added device mass on each limb segment (mi). The AF
increases with p
+ since adding positive mechanical
power to the body reduces positive muscle-tendon work.
In distinction, the AF decreases if an exoskeleton
removes more mechanical energy from the body than it
supplies, denoted by a negative net-power dissipation
(p
dis). The musculoskeletal complex utilizes elastic ele-
ments to efficiently store and release energy during level
ground walking [8,26,27]. Negative net-power removed
by an exoskeleton, p
dis, cannot be stored elastically and
reused by the body, resulting in additional positive
muscle-tendon work and an increased metabolic rate. A
graphical representation showing the relationship be-
tween p
+ and p
dis is shown (Figure 2). The muscle-
tendon efficiency, η, is used in (4) to convert exoskeletal
mechanical power to metabolic power. This value was
obtained by taking the mean of efficiency values empiri-
cally determined in previously published exoskeleton
studies, η=0.41 mechanical Watts for every metabolic
Watt [20,22]. As such, 41 W of positive mechanical
power supplied by an exoskeleton replaces 100 W of
metabolic power. The empirically obtained efficiency is
consistent with previous studies investigating the posi-
tive muscle fascicle work efficiency of 0.25 [28-30],
which is a lower efficiency limit for joint positive power
since energy stored elastically in tendons and ligaments
and released during concentric muscle-tendon con-
tractions have a positive impact on such an efficiency
[19,20]. Finally, the AF also accounts for the metabolic
burden due to additional leg mass by the sum of the
products of the device location factors (βi) and the exo-
skeletal component masses (mi). The included exoskel-
etal masses are those worn on the foot, shank, thigh and
waist (enumerated by i in equation 4). The device loca-
tion factors (βi) are 14.8, 5.6, 5.6, and 3.3 W/kg from
ankle to waist, respectively [17]. Browning et al. provided
linear regression equations for each segment that relate
added mass to net metabolic rate normalized by body
mass. The device location factors were obtained by tak-
ing the product of the linear regression slopes and the
average subject mass studied by Browning et al.
Results
Actuator calibration
The calibration tests were performed with a sinusoidal
motor position profile, over a range of frequencies (1–
4 Hz) with an amplitude of 150 mm. The corresponding
force amplitudes ranged from 0 to 350 N. These values
were chosen because they are similar to the actuator
range of motion and force experienced during walking.
The calibration tests demonstrated a positive power
transfer efficiency (η
+) of 0.68 ±0.01 (mean ± standard
error) and a negative power transfer efficiency (η
−)o f
0.77 ±0.01, resulting in an average root mean square
error of 10 W over the range of tested frequencies and
Figure 2 Calculation of negative net-power dissipation term,
p
dis. Various power profiles are shown with the corresponding
positive and dissipative powers. Note that when mean positive
power is greater than the mean negative power, the dissipative
term is zero.
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(2) were used to estimate the power applied by the exo-
skeleton during human trials.
Metabolic and mechanical power
The exoskeleton significantly reduced the metabolic
power required to walk at 1.5 m/s with a 23 kg load.
Standing with the 23 kg load required 1.85 ±0.11 W/kg
and walking without the exoskeleton required 6.98 ±
0.24 W/kg, agreeing with previous work [31,32]. The
average metabolic cost of walking with the exoskeleton
was 6.56 ±0.29 W/kg. Use of the autonomous leg exo-
skeleton significantly reduced the metabolic cost of
walking by 36±12 W, which was an improvement of
8±3% (p =0.025) relative to the control condition
(Figure 3). The exoskeleton reduced the metabolic
cost for six of the seven subjects. During walking, the
exoskeleton applied a mean positive mechanical po-
wer of 23±2 W (11.5 W per ankle) to the wearer
during the push-off portion of stance phase (Figure 3).
The metabolic and mechanical power results for each
subject are shown in Table 2.
The measured electrical power suggests that the cur-
rent exoskeleton can provide assistance for over 10 km
of walking. The average electrical power was measured
to be 49±5.3 W. If one hundred percent of the battery’s
energy was used, or 432 kJ, then the exoskeleton would
have a battery life of 2.4 hours, or 13 km at 1.5 m/s.
Augmentation factor comparison
To elucidate the mechanisms that underlie the metabolic
performance of leg exoskeletons in walking, the AF was
calculated for the presented device, as well as for other
previously published exoskeletons that reported meta-
bolic and mechanical power information (Figure 4 and
Table 3). The included previous studies span a large range
of device designs and metabolic impacts [9,10,12,20,22].
Researchers have used springs, damping elements, and ac-
tuators in various arrangements, with all previously pub-
lished autonomous exoskeletons increasing metabolic
energy consumption, and only non-autonomous, tethered
exoskeletons decreasing metabolic demand. Using linear
regression, the AF was able to explain the metabolic re-
sults of all exoskeletons with an R
2 equal to 0.98.
Discussion
The metabolic and mechanical power results support
the hypothesis that a metabolic reduction during walking
with a load can be achieved by an autonomous leg exo-
skeleton capable of providing substantial positive mechan-
ical power with minimal added distal mass. The metabolic
reduction provided by the exoskeleton is equivalent to re-
ducing the payload by approximately 7 kg or 30% of the
original payload of 23 kg [32].
The lightweight architecture of the exoskeleton al-
lowed it to add positive mechanical power to the user
without restricting the natural motions of the ankle
joint. In order to apply a large torque about the ankle
joint, it must be reacted by both a structure connected
to the foot and a structure connected to the shank. Ap-
plying large forces to the body must be done carefully,
in order to prevent discomfort or pain. One solution is
Figure 3 Mechanical and metabolic results of wearing the
autonomous exoskeleton. (A) Inter-subject mean exoskeletal ankle
power provided by only the exoskeleton is shown (blue) throughout
a single gait cycle, while carrying load. Power is normalized by body
mass with standard deviation shown in translucent. For comparison,
the mechanical power provided by only the biological ankle joint is
shown (dashed red) in the case of fast walking without a load or
exoskeleton, acquired from a reference dataset [33]. The normalized
maximum mechanical power produced by the ankle while walking
with a 20 kg load has been shown to increase to over 6 W/kg [23].
(B) Inter-subject mean change in mechanical and metabolic power
is shown when using the exoskeleton is compared to not using the
exoskeleton, with error bars denoting standard error. The increase in
exoskeletal mechanical power demonstrates how much positive
mechanical power is provided to the wearer by the exoskeleton. The
decrease in metabolic power demonstrates the reduction in the rate
of metabolic energy consumed while wearing the exoskeleton.
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joint which greatly reduces the shear forces on the foot
and shank [4,18,36]. However, the mechanical bearing
must be closely aligned with the biological joint in order
to prevent undesired forces and translations, and a bear-
ing at the ankle joint adds non-trivial distal mass. Other
exoskeletons have developed various methods to apply
moments about a joint without a parallel bearing, but
these devices have been limited in the amount of torque
they can apply [37,38]. Instead, the presented device cre-
ates a rigid extension of the foot in only the plantar-
flexion direction. Actuating the struts with a cord does
not constrain the movement of the ankle and subtalor
joints, and also reduces the distal mass, since the boot is
only connected to the heel cord and a fiberglass strut.
The freedom of the ankle and subtalor joints may have
also contributed to the success of this device, but this ef-
fect would be difficult to measure and quantify.
The AF suggests the importance of an exoskeleton to
provide substantial positive mechanical power to the
wearer with minimal added leg mass and net-negative
power dissipation. That is, using the fundamental char-
acteristics of device mechanical power and mass, the
potential metabolic impact can be estimated using the
AF. The metabolic results observed in this study were
achieved by a device with an AF of 33 W. Previously, the
most successful published exoskeleton (Malcom et al.)
had an AF of 10 W. That device was tethered, having an
external power supply and yet showed one third the
metabolic improvement (12 W) of the device we present
in this paper (36 W) [22]. Historically, previously pub-
lished autonomous exoskeletons have not provided a
metabolic improvement, demonstrated by their negative
AF values (Figure 4). In accordance with the AF, to de-
sign a non-dissipating exoskeleton (p
dis=0) that reduces




βimi (4). Furthermore, a purely
dissipative device (p
+ =0 and p
dis<0) will have a nega-
tive AF (e.g. [10]) and an estimated increase in metabolic
cost. Future investigators can use the AF to estimate the
metabolic impact of an exoskeletal leg design, reducing
the likelihood of the device unintentionally increasing
walking metabolic energy once fabricated.
Table 2 Metabolic power, mechanical power and augmentation for seven subjects
No Device Exoskeleton
Subj. Mass Metabolic Metabolic Augmentation Avg. mech. pow.
(kg) (W) (W) (%) (W)
1 82 397 338 14.6 23.4
2 75 408 378 7.4 NA*
3 84 411 332 19.2 28.5
4 80 330 320 3.1 15.1
5 85 502 513 −2.2 25.1
6 89 428 408 4.7 17.7
7 93 541 486 10.2 26.8
Mean 84 431 396 8.2 22.8
SEM 2 26 29 2.7 2.0
The metabolic power while wearing the exoskeleton is compared to the metabolic power while wearing no device. The net metabolic power is the measured
metabolic rate of walking minus the measured metabolic rate of standing. The average mechanical power is estimated by the applied voltage, motor velocity and
experimentally determined actuator efficiency. The means and standard error mean (SEM) are presented in the bottom row. *The wireless telemetry
malfunctioned for subject 2.
Figure 4 Augmentation Factor (AF). The AF was calculated for six
devices and compared to the measured metabolic impact for each
device [9,10,12,20,22]. Triangle markers are previously published
autonomous devices, square markers are previously published
tethered devices, and the circle marker is the presented
autonomous exoskeleton of this study. The equation estimated by
linear regression is y=1.1x – 4 with an R
2 equal to 0.98. In the AF
equation, the p
+ term is calculated by taking the positive work done
by an exoskeleton during the gait cycle and dividing by the gait
cycle duration. If the net-work done by the exoskeleton is negative,
then p
dis is equal to this negative net-work divided by the gait cycle
duration, otherwise, p
dis is zero.
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AF that must be considered carefully. The AF does not
account for different control schemes and only accounts
for mechanical power and added distal mass. That is,
the AF assumes that power is added in a biomimetic
fashion where positive and negative power are added by
the exoskeleton during phases of the gait cycle when the
joint is also applying positive or negative power, respect-
ively. Current and previous exoskeletal control method-
ologies apply power in this way. The muscle-tendon
efficiency of 0.41 used by the AF is also an estimate
based on two studies [20,22]. The muscle-tendon effi-
ciency may also be specific for each joint and activity
[34,39]. More studies are needed to precisely determine
how this apparent muscle-tendon efficiency is affected
by joint and activity. Furthermore, the transfer of mech-
anical energy between joints is not fully considered when
calculating the AF. Literature suggests that energy is
transferred between joints via bi-articular muscle-tendon
action when one joint is performing negative power and
another is exhibiting positive power [26,27]. This may
explain why the device presented by Donelan et al. in-
creased the metabolic rate higher than predicted by the
AF [10]; a knee exoskeleton that harvests electrical en-
ergy from negative phases of knee mechanical work may
reduce the mechanical energy transferred to the hip via
bi-articular muscle-tendon units, potentially increasing
muscular hip work and adversely affecting metabolism.
The possible metabolic advantage of an exoskeleton redu-
cing the negative mechanical power applied by muscle-
tendon units is also not considered by the AF. Providing a
joint with negative power during phases of eccentric
muscle work may reduce the metabolic burden. However,
muscles are substantially more efficient at eccentric work
than they are at concentric work [8], thus, aiding the joints
during eccentric phases is less effective at reducing the
metabolic expenditure during walking, when compared to
aiding concentric contraction phases.
The equation found by linear regression of the AF and
measured metabolic effect, y=1.1x-4, (95% C.I. slope:
[0.86, 1.33] (p=0.0002), intercept: [−15, 7] (p= 0.38)),
highlights some important features of the AF. When no
device is worn the AF should predict no metabolic
change; that is, a device that does not supply power and
has no mass should have no metabolic effect. The nearly
zero y-intercept correctly accounts for this case. The
slope of the linear regression is approximately one, indi-
cating the ability of the AF to predict metabolic change
caused by a worn exoskeleton. The AF includes the
aforementioned assumptions as well as the empirically-
estimated muscle-tendon efficiency for positive mechan-
ical work (η). Future work will focus on the validation of
these assumptions.
In this work, comparisons are made between exoskele-
tons that were tested with load carriage and those that
were tested during unloaded conditions. The effect of
added load on the metabolic improvement of an exoskel-
eton is unknown, but may be an advantage compared to
unloaded studies. Because of the limited number of stud-
ies documenting the metabolic impact of exoskeletal walk-
ing, the calculation of the AF in this study assumed that
the muscle-tendon efficiency was not affected by different
loading conditions.
Future improvements of the autonomous exoskeleton
should increase the versatility and controllability of the
device. Reducing the posterior protrusion of the struts
will allow for a greater range of motion. An integrated
force sensor will also allow for more precise torque con-
trol. While using motor state to apply a torque impulse
was successful, more sophisticated control paradigms
will require a greater level of force measurement. The
maximum applied mechanical power and relative timing
varied by subject due to the subtle differences in how
the subjects utilized the exoskeleton. The timing of the
push-off assistance was statically determined before the
exoskeleton trial and did not adapt with changes in step
Table 3 Augmentation factor calculation for six studies
Study Mass p
+ p




impact (kg) (W) (W) (kg) (kg) (kg) (kg)
(W) (W) (W)
van Dijk et al. [12]7 5 3 0 3 *3 * 3 *3 * 8 8 −81 −90
Walsh et al. [9]7 6 7 −5 1.41 1.41 5.12 3.66 69 −64 −67
Donelan et al. [10]7 8 0 −9 0 1.6 1.6 0 18 −40 −62
Malcolm et al. [22] 66 9 0 0.4** 1.1** 0 0 12 10 12
Sawicki & Ferris [20,34] 80 16 0 .75 2.0 0 0 22 17 10
Present Study 84 23 0 0.5 1.75 0 1.71 23 33 36
Six studies were found that reported both metabolic results and applied mechanical power [9,10,12,20,22,35]. Powers that were not explicitly stated in literature
were computed from provided graphs. The included exoskeletal masses are those worn on the foot, shank, thigh and waist (enumerated by i in equation 4).
The β coefficient was 14.8 W/kg for mass added to the foot, 5.62 W/kg for the shank, 5.55 W/kg for the thigh, and 3.33 for the waist [17]. *The location of the
exoskeleton mass was not described, so the mass was evenly distributed across the leg. **The exact location of the exoskeleton mass was not described, but the
device is similar to the device studied by Sawicki & Ferris, so the same mass distribution was used.
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consistent timing that the subjects could rely on, but it
also may have forced the subjects to walk at a non-
optimal cadence while wearing the exoskeleton. Future
control strategies should be able to adapt to the natural
cadence of the user. Finally, a fully autonomous exoskel-
eton presents the opportunity to develop controls for ac-
tivities other than walking in a laboratory. Specifically,
gait transitions and terrain adaptations will be an excit-
ing area of future investigation.
Conclusions
In this study, a fully autonomous leg exoskeleton was
described that reduced the metabolic burden of walking
during load carriage. In accordance with the Augmenta-
tion Factor framework, the applied mechanical power
characteristics of the device coupled with the distal mass
were critical factors to its success. The presented exo-
skeleton could reduce the metabolic burden of indi-
viduals expected to carry substantial loads. Instead of
reducing the metabolic burden, the device may allow
them to carry greater loads at their nominal metabolic
cost. A lightweight autonomous powered exoskeleton
enables the investigation of real-world applications in-
cluding the complex controls needed for various terrains
and conditions outside of the laboratory.
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